Microglial Senescence in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives.
Abstract
The global aging population has led to a rising incidence of neurodegenerative diseases, casting a significant shadow on global health due to their complex and multifactorial nature. In addition to genetic predispositions, cellular senescence, particularly in microglia, the innate immune cells of the central nervous system, has become a significant contributor to neurodegeneration. In this review, we examine the mechanism of microglial senescence in neurodegenerative disease. We emphasize the need for continuous exploration of microglial senescence mechanisms and provide a future perspective for developing preventive drugs, encouraging researchers to develop new therapies for patients with neurodegenerative diseases.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that microglial senescence contributes to neurodegeneration and emphasizes the need for therapeutic interventions targeting this process. The focus on microglial senescence as a mechanism in neurodegenerative diseases aligns with the exploration of aging-related cellular processes, making it relevant to longevity research.
Author of this paper? Send a correction.